Affiliated with Université Laval & CERVO Research Centre

Publications

Export 6 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Analgesics  [Clear All Filters]
2015
Ford A, Castonguay A, Cottet M, Little JW, Chen Z, Symons-Liguori AM, Doyle T, Egan TM, Vanderah TW, De Konnick Y, Tosh DK, Jacobson KA, Salvemini D.  2015.  Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain.. J Neurosci. 35(15):6057-67.
2014
Bergeron MJ, Castonguay A, De Koninck Y.  2014.  [KCC2: a new therapeutical target for the treatment of neurological diseases].. Med Sci (Paris). 30(5):514-7.
2013
Gagnon M, Bergeron MJ, Lavertu G, Castonguay A, Tripathy S, Bonin RP, Perez-Sanchez J, Boudreau D, Wang B, Dumas L, Valade I, Bachand K, Jacob-Wagner M, Tardif C, Kianicka I, Isenring P, Attardo G, Coull JAM, De Koninck Y.  2013.  Chloride extrusion enhancers as novel therapeutics for neurological diseases.. Nat Med. 19(11):1524-8.
Bonin RP, De Koninck Y.  2013.  Restoring ionotropic inhibition as an analgesic strategy.. Neurosci Lett. 557 Pt A:43-51.
2005
Price TJ, Cervero F, De Koninck Y.  2005.  Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia.. Curr Top Med Chem. 5(6):547-55.